Cardiovascular outcome trials of the incretin-based medicines tirzepatide and semaglutide have shown benefits in populations with varying levels of cardiovascular risk. However, without direct head-to-head comparisons, treatment decisions rely on…
Adult patients treated for
Data from the Does Eliminating Coffee…
DALLAS, Nov. 9, 2025 — More than 28 million people worldwide are living with heart valve disease, and the numbers are climbing. In the U.S., the condition contributes to more than 60,000 deaths each year. [1] Yet many people are…
NEW ORLEANS, LA—For patients with atrial fibrillation (AF) who are at high risk of both stroke and…
NEW ORLEANS, LA—In good news for coffee drinkers with atrial fibrillation (AF)—maintaining the habit…
As the days get shorter and temperatures drop, many people start to feel a noticeable shift in their mood, a condition known as seasonal affective disorder.
This type of depression — commonly known as SAD — happens around the same time every…
A newly presented exploratory cohort analysis showed that individuals who were apolipoprotein (APOE) ϵ4/ϵ4 carriers were significantly more likely to have biomarker results indicating symptomatic or at-risk status for mild cognitive impairment…
ORLANDO — Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy…